Real World Experience with the HeartMate 3 (HM3) Left Ventricular Assist Device (LVAD): Analysis of the First 125 Consecutive Patients at a Single Institution

E.J. Molina,S.S. Najjar,S. Ahmed, M.E. Rodrigo, M. Hofmeyer, A. Kadakkal, S.F. Mohammed, P.H. Lam, H. Kitahara, F.H. Sheikh

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2020）

引用 0|浏览7

暂无评分

摘要

In this single center, real world experience, HeartMate 3 implantation was associated with excellent survival comparable to those demonstrated in a recent clinical trial. The incidence of complications was also low, including no episodes of suspected or confirmed pump thrombosis.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要